Popularized in films like Limitless, legal smart drugs called Nootropics are becoming more and more prevalent in board rooms and on Wall Street.Keep reading »
JPMorgan Exec. Sleeps On It, Decides She’s Got Better Things To Do Than Hang Out With Acting CFTC ChairmanBy Jon Shazar
Blythe Masters, JPMorgan Chase & Co.’s commodities head, withdrew from an advisory committee of the U.S. Commodity Futures Trading Commission a day after her appointment was disclosed, according to two people with direct knowledge of the decision.
The regulator may include another executive from New York-based JPMorgan on the global markets committee, said one person close to the bank who requested anonymity because the move hasn’t been publicly announced. Masters, 44, stepped down because the company’s sale of its physical commodities unit will keep her occupied, the person said….
Masters, whose name appeared on a list of committee members on the CFTC’s website yesterday, had been scheduled to participate in a Feb. 12 meeting to discuss cross-border guidance on rules. She was invited to the panel by acting Chairman Mark Wetjen, said one of the people. Her name has since been removed from the list.
JPMorgan’s Masters Said to Quit CFTC Panel After One Day [Bloomberg]
JPMorgan’s Blythe Masters to Join Swaps Regulatory Panel [Bloomberg]
JPMorgan in talks with Mercuria on commodities unit sale [Reuters]